171 related articles for article (PubMed ID: 3054127)
1. Combining chemotherapy with biological response modifiers in treatment of cancer.
Mitchell MS
J Natl Cancer Inst; 1988 Nov; 80(18):1445-50. PubMed ID: 3054127
[TBL] [Abstract][Full Text] [Related]
2. Principles of combining biomodulators with cytotoxic agents in vivo.
Mitchell MS
Semin Oncol; 1992 Apr; 19(2 Suppl 4):51-6. PubMed ID: 1553575
[TBL] [Abstract][Full Text] [Related]
3. Combination of active specific immunotherapy or adoptive antibody or lymphocyte immunotherapy with chemotherapy in the treatment of cancer.
Zhang T; Herlyn D
Cancer Immunol Immunother; 2009 Apr; 58(4):475-92. PubMed ID: 18925393
[TBL] [Abstract][Full Text] [Related]
4. Immunological consequences of chemotherapy: Single drugs, combination therapies and nanoparticle-based treatments.
Pusuluri A; Wu D; Mitragotri S
J Control Release; 2019 Jul; 305():130-154. PubMed ID: 31004668
[TBL] [Abstract][Full Text] [Related]
5. The interplay of immunotherapy and chemotherapy: harnessing potential synergies.
Emens LA; Middleton G
Cancer Immunol Res; 2015 May; 3(5):436-43. PubMed ID: 25941355
[TBL] [Abstract][Full Text] [Related]
6. Design of combination biotherapy studies: future goals and challenges.
Gilewski TA; Golomb HM
Semin Oncol; 1990 Feb; 17(1 Suppl 1):3-10; discussion 38-41. PubMed ID: 1689077
[TBL] [Abstract][Full Text] [Related]
7. Marrying immunotherapy with chemotherapy: why say IDO?
Muller AJ; Prendergast GC
Cancer Res; 2005 Sep; 65(18):8065-8. PubMed ID: 16166276
[TBL] [Abstract][Full Text] [Related]
8. Does chemotherapy augment anti-tumor immunotherapy by preferential impairment of regulatory T cells?
Zhang L; Dermawan KT; Jin ML; Xiong SD; Chu YW
Med Hypotheses; 2008 Nov; 71(5):802-4. PubMed ID: 18691831
[TBL] [Abstract][Full Text] [Related]
9. [Chemotherapy and Anticancer Immune Responses].
Harada M
Gan To Kagaku Ryoho; 2016 May; 43(5):571-7. PubMed ID: 27210085
[TBL] [Abstract][Full Text] [Related]
10. Immunomodulation by cancer chemotherapeutic agents and antineoplastic activity.
Spreafico F; Mantovani A
Pathobiol Annu; 1981; 11():177-95. PubMed ID: 6460217
[No Abstract] [Full Text] [Related]
11. Immunogenic chemotherapy: Dose and schedule dependence and combination with immunotherapy.
Wu J; Waxman DJ
Cancer Lett; 2018 Apr; 419():210-221. PubMed ID: 29414305
[TBL] [Abstract][Full Text] [Related]
12. Combinations Therapies.
Reinmuth N; Reck M
Prog Tumor Res; 2015; 42():79-94. PubMed ID: 26384009
[TBL] [Abstract][Full Text] [Related]
13. Mixed immunotherapy and chemotherapy of tumors: modeling, applications and biological interpretations.
de Pillis LG; Gu W; Radunskaya AE
J Theor Biol; 2006 Feb; 238(4):841-62. PubMed ID: 16153659
[TBL] [Abstract][Full Text] [Related]
14. Adapting conventional cancer treatment for immunotherapy.
Qiao J; Liu Z; Fu YX
J Mol Med (Berl); 2016 May; 94(5):489-95. PubMed ID: 26910191
[TBL] [Abstract][Full Text] [Related]
15. Biological response modifiers (BRM), chemotherapy, and activated cytotoxic leukocyte subsets: strategies for rational design of apheresis-based cancer immunotherapies.
Stevenson HC; Klein HG
Prog Clin Biol Res; 1990; 337():559-65. PubMed ID: 2353018
[No Abstract] [Full Text] [Related]
16. [Combination of chemotherapy and immunotherapy in man--review].
Ohnuma T
Gan To Kagaku Ryoho; 1990 Aug; 17(8 Pt 1):1428-36. PubMed ID: 1697154
[TBL] [Abstract][Full Text] [Related]
17. [Immunomodulation in cancer. What do we do and where do we go?].
Rodríguez Orozco AR; Serriteño NM
Rev Alerg Mex; 2005; 52(2):96-101. PubMed ID: 16158783
[TBL] [Abstract][Full Text] [Related]
18. Biological response modifiers for the therapy of cancer.
Herberman RB
Ann Allergy; 1985 May; 54(5):376-80. PubMed ID: 3994067
[TBL] [Abstract][Full Text] [Related]
19. Novel mechanism of synergistic effects of conventional chemotherapy and immune therapy of cancer.
Ramakrishnan R; Gabrilovich DI
Cancer Immunol Immunother; 2013 Mar; 62(3):405-10. PubMed ID: 23423351
[TBL] [Abstract][Full Text] [Related]
20. Immuno-pharmacodynamics for evaluating mechanism of action and developing immunotherapy combinations.
Parchment RE; Voth AR; Doroshow JH; Berzofsky JA
Semin Oncol; 2016 Aug; 43(4):501-13. PubMed ID: 27663482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
